DZ2654A1 - Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose. - Google Patents

Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose.

Info

Publication number
DZ2654A1
DZ2654A1 DZ980264A DZ980264A DZ2654A1 DZ 2654 A1 DZ2654 A1 DZ 2654A1 DZ 980264 A DZ980264 A DZ 980264A DZ 980264 A DZ980264 A DZ 980264A DZ 2654 A1 DZ2654 A1 DZ 2654A1
Authority
DZ
Algeria
Prior art keywords
ketolides
atherosclerosis
preparation
pharmaceutical compositions
compositions intended
Prior art date
Application number
DZ980264A
Other languages
English (en)
French (fr)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DZ2654A1 publication Critical patent/DZ2654A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DZ980264A 1997-11-17 1998-11-16 Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose. DZ2654A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
DZ2654A1 true DZ2654A1 (fr) 2003-03-22

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980264A DZ2654A1 (fr) 1997-11-17 1998-11-16 Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose.

Country Status (35)

Country Link
US (1) US20080139489A1 (id)
EP (1) EP1030673B1 (id)
JP (1) JP4550273B2 (id)
KR (1) KR20010032130A (id)
CN (1) CN1286633A (id)
AP (1) AP1196A (id)
AR (1) AR014119A1 (id)
AT (1) ATE271875T1 (id)
AU (1) AU744419B2 (id)
BG (1) BG104427A (id)
BR (1) BR9814199A (id)
CA (1) CA2312021C (id)
DE (1) DE69825308T2 (id)
DZ (1) DZ2654A1 (id)
EA (1) EA003322B1 (id)
EE (1) EE04095B1 (id)
ES (1) ES2224446T3 (id)
FR (1) FR2771008B1 (id)
GE (1) GEP20032968B (id)
HR (1) HRP20000314A2 (id)
HU (1) HUP0004507A3 (id)
ID (1) ID24940A (id)
IL (1) IL136149A0 (id)
MA (1) MA26566A1 (id)
NO (1) NO20002435L (id)
NZ (1) NZ504305A (id)
OA (1) OA11411A (id)
PL (1) PL340373A1 (id)
SK (1) SK7042000A3 (id)
TN (1) TNSN98206A1 (id)
TR (1) TR200001384T2 (id)
TW (1) TW472061B (id)
WO (1) WO1999025365A1 (id)
YU (1) YU29600A (id)
ZA (1) ZA9810357B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
HUP0300370A3 (en) 2000-04-04 2005-07-28 Smithkline Beecham Plc 2-hydroxy-mutilin carbamate derivatives of antibacterial effect process for preparation and pharmaceutical compositions containing them
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency 14員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2249892A (en) * 1991-06-14 1993-01-12 Board Of Regents Of The University Of Washington, The Diagnosis and treatment of arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20002435D0 (no) 2000-05-11
YU29600A (sh) 2003-02-28
NO20002435L (no) 2000-07-07
JP4550273B2 (ja) 2010-09-22
WO1999025365A1 (fr) 1999-05-27
BG104427A (en) 2001-02-28
CA2312021A1 (fr) 1999-05-27
BR9814199A (pt) 2000-09-26
EP1030673A1 (fr) 2000-08-30
DE69825308D1 (de) 2004-09-02
EE200000244A (et) 2001-06-15
DE69825308T2 (de) 2005-08-04
AU744419B2 (en) 2002-02-21
SK7042000A3 (en) 2000-12-11
JP2001523644A (ja) 2001-11-27
TNSN98206A1 (fr) 2005-03-15
AU1242599A (en) 1999-06-07
HUP0004507A3 (en) 2001-12-28
CN1286633A (zh) 2001-03-07
AP2000001825A0 (en) 2000-06-30
ES2224446T3 (es) 2005-03-01
GEP20032968B (en) 2003-05-27
KR20010032130A (ko) 2001-04-16
AR014119A1 (es) 2001-02-07
EA003322B1 (ru) 2003-04-24
TW472061B (en) 2002-01-11
ZA9810357B (en) 1999-11-12
TR200001384T2 (tr) 2001-06-21
EP1030673B1 (fr) 2004-07-28
PL340373A1 (en) 2001-01-29
HRP20000314A2 (en) 2001-02-28
CA2312021C (fr) 2008-08-26
US20080139489A1 (en) 2008-06-12
EE04095B1 (et) 2003-08-15
HUP0004507A1 (hu) 2001-05-28
AP1196A (en) 2003-08-18
EA200000531A1 (ru) 2000-10-30
NZ504305A (en) 2002-11-26
FR2771008B1 (fr) 2000-04-28
ATE271875T1 (de) 2004-08-15
IL136149A0 (en) 2001-05-20
ID24940A (id) 2000-08-31
MA26566A1 (fr) 2004-12-20
OA11411A (fr) 2004-04-20
FR2771008A1 (fr) 1999-05-21

Similar Documents

Publication Publication Date Title
CA2206837A1 (fr) Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
DZ2595A1 (fr) Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs et procédépour leur préparation.
ATE255819T1 (de) Zusammensetzungen von süssigkeiten
FR2589910B1 (fr) Ensemble d'elements de construction assemblables pour former des ouvrages tels que des murs de soutenement.
DZ1958A1 (fr) Composés inhibiteurs de l'enzyme l-lpa compositionpharmaceutiques les composant et procédés pour leur préparation.
EP0812212A4 (en) PREPARATIONS FOR THE ADMINISTRATION OF ANTIGENS
ZA964624B (en) Process for the preparation of microcapsule compositions.
BR9708793A (pt) Composições ácidas redutoras de cisalhamento espessas
EP0756827A3 (de) Präparat zur Ernährung
DZ2752A1 (fr) Composés et compositions pharmaceutiques pour le traitement du paludisme.
MA22946A1 (fr) Compositions de precurseurs d'agents de blanchiment.
DZ2550A1 (fr) Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2316A1 (fr) Micro sphères pharmaceutiques d'acide valproique pour administration orale.
CA2340224A1 (en) Nimesulide containing topical pharmaceutical compositions
BR9306531A (pt) Composições de mistura de bebida de psílio
DZ2641A1 (fr) Nouveaux procédés pour la préparation d'oméprazole.
MA23900A1 (fr) Procede pour la preparation de compositions antiretrovirale
MA26566A1 (fr) Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose.
CA2337667A1 (en) Dextran-leptin conjugates, pharmaceutical compositions and related methods
MA25184A1 (fr) Production d'acide pour aliments .
FR2718354B1 (fr) Application des composés antiglucocorticoïde pour la préparation de médicaments destinés à la prévention ou au traitement des manifestations liées au syndrome de sevrage des narcotiques et les compositions les renfermant.
AU4244996A (en) Buffered emulsion compositions containing actives subject to acid or base hydrolysis
DZ1779A1 (fr) Procédé pour la préparation de particules préparées à sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules.
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
CA2314541A1 (fr) Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute